Specialists for Leiomyosarcoma

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Suzanne George, MD
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
QC-verified PI×6
Patricia Pautier, MD
Rare Disease / Clinical Research
Gustave Roussy, Cancer Campus, Grand Paris
QC-verified PI×1
Mia C Weiss, MD
Rare Disease / Clinical Research
Yale University Cancer Center LAO
SAINT LOUIS, MO
QC-verified PI×1 72
Maria Rios
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Axel Le Cesne
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Isabelle Ray-Coquard
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 2
Patricia Pautier
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Christine Chevreau
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Nicolas Penel
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Nelly Firmin
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Pascaline Boudou-Rouquette
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
François Bertucci
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Valérie Lebrun-Ly
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Elsa Kalbacher
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Emmanuelle Bompas
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Olivier Collard
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Nicolas Isambert
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Cécile Guillemet
Rare Disease / Clinical Research
University of Bordeaux
QC-verified 1
Frédéric Amant, MD PhD
Rare Disease / Clinical Research
UZ Leuven
PI×1
Elise F Nassif, MD
Rare Disease / Clinical Research
University of Texas MD Anderson Cancer Center LAO
HOUSTON, TX
PI×1
Helen E Heslop, MD, MD
Rare Disease / Clinical Research
Baylor College of Medicine
HOUSTON, TX
PI×6
Lillian Siu, MD
Rare Disease / Clinical Research
Princess Margaret Hospital, Canada
PI×14
Martee Hensley, MD
Rare Disease / Clinical Research
Gynecologic Oncology Group
NEW YORK, NY
PI×4 4
Robert Maki, MD, PhD, MD, PhD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PHILADELPHIA, PA
PI×8
Sant P Chawla, MD, M.D
Rare Disease / Clinical Research
Sarcoma Oncology Research Center
SANTA MONICA, CA
PI×5
Florence DUFFAUD, MD
Rare Disease / Clinical Research
La TIMONE University Hospital
PI×3
Robert Maki, MD, PhD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PHILADELPHIA, PA
PI×1 6
Glen Lew, MD
Rare Disease / Clinical Research
Pierre Fabre Laboratories
ATLANTA, GA
PI×1
Federica Cattaneo
Rare Disease / Clinical Research
Pierre Fabre Laboratories
PI×1 5
Gregory P. Sutton, MD
Rare Disease / Clinical Research
St. Vincent Gynecologic Oncology at St. Vincent Oncology Center
PI×3 1
Scott Schuetze, MD, PhD
Rare Disease / Clinical Research
SWOG Cancer Research Network
ANN ARBOR, MI
PI×3
D. McMeekin
Rare Disease / Clinical Research
Gynecologic Oncology Group
PI×4
Philipp Harter, MD
Rare Disease / Clinical Research
Klinikum Essen Mitte
PI×2
Claire Friedman, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×1
Mark Dickson
Rare Disease / Clinical Research
Alliance for Clinical Trials in Oncology
PI×1 2
Vishruth Reddy, MD, PhD, M.D., Ph.D
Rare Disease / Clinical Research
UCLA / Jonsson Comprehensive Cancer Center
LOS ANGELES, CA
PI×1
Vincent Chung, MD, MD
Rare Disease / Clinical Research
City of Hope Medical Center
DUARTE, CA
PI×4
Edwin Choy, MD, PhD, MD PhD
Rare Disease / Clinical Research
Massachusetts General Hospital
BOSTON, MA
PI×3
Michael Heinrich, MD
Rare Disease / Clinical Research
Oregon Health and Science University
PI×1
Michael B Gill
Power Life Sciences Inc.
QC-verified PI×22
Breelyn Wilky, MD
University of Colorado, Denver
AURORA, CO
QC-verified PI×2
Martee L Hensley, MD
NRG Oncology
NEW YORK, NY
QC-verified PI×1
Pedro Hermida de Viveiros
Northwestern University
QC-verified PI×1
Gabriel Tinoco
Ohio State University Comprehensive Cancer Center
QC-verified PI×1
Daniel Stark
University of Leeds
QC-verified PI×1
Katherine Y. Look, RN
Indiana University Melvin and Bren Simon Cancer Center
EASTLAKE, OH
QC-verified PI×1
Peter W. Pisters, M.D
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×1
Roberta Sanfilippo
Fondazione IRCCS INT di Milano
QC-verified PI×1
Kristyna Hlinecka
Charles University, Czech Republic
QC-verified PI×1
David Liebner, MD
Ohio State University Comprehensive Cancer Center
COLUMBUS, OH
QC-verified PI×1
Wei-Wu Chen
National Taiwan University Hospital
QC-verified PI×1
Donald G. Gallup, M.S
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
ADA, OK
QC-verified PI×1
David Hyman
NRG Oncology
QC-verified PI×1
Harry J. Long, MRSS/Clergy/Pastoral
Mayo Clinic
PARIS, MO
QC-verified PI×1
Bruno Vincenzi
Campus Biomedico of Rome
QC-verified PI×1
Janet Yoon
City of Hope Medical Center
BAKERSFIELD, CA
QC-verified PI×1
Scott H. Okuno, M.D
Mayo Clinic, Rochester, MN
ROCHESTER, MN
QC-verified PI×1
Marilyn Huang, L.Ac
University of Miami
PORTLAND, OR
QC-verified PI×1
Sujana Movva, MD
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
QC-verified PI×1
Gregory M Cote, MD, PHD
Rare Disease / Clinical Research
Massachusetts General Hospital
BOSTON, MA
PI×1

More about Leiomyosarcoma

Disease overview →
Treatments →
Clinical trials →